Table 2. Comparison of quantitative clinical factors between MVI- Negative group and MVI- Positive group.
Factors | MVI- Negative | MVI- Positive | P value | ||
---|---|---|---|---|---|
Mean | Standard deviation | Mean | Standard deviation | ||
Age (years) | 55.110 | 9.509 | 54.682 | 8.728 | 0.804 |
Abl (g/L) | 37.553 | 6.088 | 35.895 | 5.734 | 0.130 |
CEA (ng/mL) | 3.285 | 2.261 | 2.563 | 1.306 | 0.056 |
AFP (μg/L) | 138.155 | 332.423 | 6627.320 | 15838.761 | 0.000 |
CA19-9(U/mL) | 93.945 | 520.080 | 185.265 | 795.579 | 0.406 |
Platelet (×103/mL) | 167.724 | 71.839 | 175.188 | 66.422 | 0.561 |
Lymphocyte (×103/mL) | 3.104 | 11.697 | 1.715 | 0.702 | 0.450 |
Neutrophil (×103/mL) | 4.593 | 2.505 | 4.196 | 2.520 | 0.385 |
PLR | 130.116 | 95.997 | 124.224 | 82.017 | 0.727 |
NLR | 3.792 | 3.725 | 2.878 | 2.074 | 0.046 |
Tumor size (cm) | 3.883 | 0.931 | 4.219 | 0.783 | 0.004 |
ALT (U/L) | 45.828 | 50.142 | 69.520 | 94.460 | 0.045 |
APRI | 0.508 | 0.571 | 0.826 | 1.194 | 0.026 |
NLR, neutrophil/lymphocyte rates; PLR, platelet/lymphocyte rates; APRI, aspartate aminotransferase / platelet rates.